Pathogens of Bacterial Pneumonia in Children and Its Drug Resistance

doi:10.3877/cma.j.issn.1673-5250.2012.02.023

Objective

To explore pathogens causing bacterial pneumonia in children and drug resistance in hospital, and supply evidence on diagnosis and therapy of a clinical basis.

Methods

From January 2009 to December 2010, a total of 892 children with bacterial pneumonia were involved in this study. All subjects were investigation by Questionnaire of Bacterial Pneumonia in Children and sample were collected. Antimicrobial susceptibility of antibiotics was detected by Kirby-Bauer method. Producing extended spectrum β-lactamases (ESBLs) bacteria were identified by double-disk synergy test. The procedure of this study was consistent with ethical standard established by the committee of investigation in human beings of Obstetrics and Gynecology Hospital of Hainan Province. And it was approved by this committee. Guardians or patients were informed of grouping and their written informed consent was obtained before clinical studies.

Results

A total of 155 pathogenic bacteria strains were isolated from 135 children, and isolation rate was 15.13%. The top five bacterial strains were Klebsiella pneumoniae, Escherichia coli, Streptococcus pneumoniae, Staphylococcus aureus and Pseudomonas aeruginosa, which accounted for 22.58%, 17.42%, 14.84%, 13.00% and 10.97% of the total bacteria strains, respectively. Drug resistance rates of Klebsiella pneumoniae, Escherichia coli, Streptococcus pneumoniae, Staphylococcus aureus and Pseudomonas aeruginosa were much more than 80% to penicillin, while much more than 77.0% to Ampicillin and amoxicillin. Drug resistance rate in 2010 was much more than that in 2009. A total of 40 producing ESBLs bacteria strains were identified by double-disk synergy test among tep five bacterial with the detection rate of 32.79%.

Conclusions

All of the bacterial pneumonia in children have the drug resistant feature, and producing ESBLs bacteria are at prevalence to a certain extent.

Key words: bacterial pneumonia, pathogen, drug resistance, child

表1 2009与2010年自本院细菌性肺炎患儿中检出细菌菌株的构成比比较[n(%)]

Table 1 Comparison of constituent ratios of the bacteria strains in bacterial pneumonia in 2009 and 2010 [n(%)]

?	细菌类别	2009年	2010年	总构成比
G^－		?	?	?
?	肺炎克雷伯菌	17 (22.97)	18 (22.22)	35 (22.58)
?	大肠埃希菌	14 (18.92)	13 (16.05)	27 (17.42)
?	铜绿假单胞菌	7 (9.46)	10 (12.35)	17 (10.97)
?	流感嗜血杆菌	3 (4.05)	4 (4.94)	7 (4.52)
?	不动杆菌	2 (2.70)	4 (4.94)	6 (3.87)
?	阴沟肠杆菌	3 (4.05)	2 (2.04)	5 (3.00)
?	溶血性链球菌	2 (2.70)	1 (1.36)	3 (2.00)
G^＋		?	?	?
?	肺炎链球菌	12 (16.22)	11 (13.58)	23 (14.84)
?	金黄色葡萄球菌	8 (10.81)	12 (15.00)	20 (13.00)
?	溶血性葡萄球菌	6 (8.11 )	6 (7.90)	12 (8.00)
?	合计	74(100.00)	81(100.00)	155(100.00)

表1 2009与2010年自本院细菌性肺炎患儿中检出细菌菌株的构成比比较[n(%)]

Table 1 Comparison of constituent ratios of the bacteria strains in bacterial pneumonia in 2009 and 2010 [n(%)]

?	细菌类别	2009年	2010年	总构成比
G^－		?	?	?
?	肺炎克雷伯菌	17 (22.97)	18 (22.22)	35 (22.58)
?	大肠埃希菌	14 (18.92)	13 (16.05)	27 (17.42)
?	铜绿假单胞菌	7 (9.46)	10 (12.35)	17 (10.97)
?	流感嗜血杆菌	3 (4.05)	4 (4.94)	7 (4.52)
?	不动杆菌	2 (2.70)	4 (4.94)	6 (3.87)
?	阴沟肠杆菌	3 (4.05)	2 (2.04)	5 (3.00)
?	溶血性链球菌	2 (2.70)	1 (1.36)	3 (2.00)
G^＋		?	?	?
?	肺炎链球菌	12 (16.22)	11 (13.58)	23 (14.84)
?	金黄色葡萄球菌	8 (10.81)	12 (15.00)	20 (13.00)
?	溶血性葡萄球菌	6 (8.11 )	6 (7.90)	12 (8.00)
?	合计	74(100.00)	81(100.00)	155(100.00)

表2 2009及2010年革兰阴性菌对常用抗菌药物的耐药率比较[n(%)]

Table 2 Comparison of the drug resistance of the G^－ bacteria against the common antibacterial drug in 2009 and 2010 [n(%)]

抗菌药物类别	2009年			2010年
抗菌药物类别	肺炎克雷伯菌(n＝17)	大肠埃希菌(n＝14)	铜绿假单胞菌(n＝7)	肺炎克雷伯菌(n＝18)	大肠埃希菌(n＝13)	铜绿假单胞菌(n＝10)
青霉素	15(88.24)	12(85.71)	6(85.71)	17(94.44)	13(100.00)	9 (90.00)
氨苄西林	16(94.12)	13(92.86)	6(85.71)	17(94.44)	13(100.00)	10(100.00)
阿莫西林	15(88.24)	12(85.71)	5(71.43)	16(88.89)	12 (92.31)	9 (90.00)
头孢唑林	9(52.94)	8(57.14)	4(57.14)	12(66.67)	9 (69.23)	8 (80.00)
氨曲南	8(47.06)	7(50.00)	4(57.14)	11(61.11)	9 (69.23)	7 (70.00)
头孢他啶	9(52.94)	11(78.57)	3(42.86)	11(61.11)	12 (92.31)	6 (60.00)
头孢噻肟	7(41.18)	7(50.00)	2(28.57)	9(50.00)	8 (61.54)	3 (30.00)
克拉维酸/头孢噻肟	2(11.76)	3(21.43)	0 (0.00)	2(11.11)	3 (23.08)	0 (0.00)
克拉维酸/头孢他啶	2(11.76)	0 (0.00)	0 (0.00)	3(16.67)	0 (0.00)	0 (0.00)
亚胺培南	0 (0.00)	0 (0.00)	0 (0.00)	0 (0.00)	0 (0.00)	0 (0.00)

表2 2009及2010年革兰阴性菌对常用抗菌药物的耐药率比较[n(%)]

Table 2 Comparison of the drug resistance of the G^－ bacteria against the common antibacterial drug in 2009 and 2010 [n(%)]

抗菌药物类别	2009年			2010年
抗菌药物类别	肺炎克雷伯菌(n＝17)	大肠埃希菌(n＝14)	铜绿假单胞菌(n＝7)	肺炎克雷伯菌(n＝18)	大肠埃希菌(n＝13)	铜绿假单胞菌(n＝10)
青霉素	15(88.24)	12(85.71)	6(85.71)	17(94.44)	13(100.00)	9 (90.00)
氨苄西林	16(94.12)	13(92.86)	6(85.71)	17(94.44)	13(100.00)	10(100.00)
阿莫西林	15(88.24)	12(85.71)	5(71.43)	16(88.89)	12 (92.31)	9 (90.00)
头孢唑林	9(52.94)	8(57.14)	4(57.14)	12(66.67)	9 (69.23)	8 (80.00)
氨曲南	8(47.06)	7(50.00)	4(57.14)	11(61.11)	9 (69.23)	7 (70.00)
头孢他啶	9(52.94)	11(78.57)	3(42.86)	11(61.11)	12 (92.31)	6 (60.00)
头孢噻肟	7(41.18)	7(50.00)	2(28.57)	9(50.00)	8 (61.54)	3 (30.00)
克拉维酸/头孢噻肟	2(11.76)	3(21.43)	0 (0.00)	2(11.11)	3 (23.08)	0 (0.00)
克拉维酸/头孢他啶	2(11.76)	0 (0.00)	0 (0.00)	3(16.67)	0 (0.00)	0 (0.00)
亚胺培南	0 (0.00)	0 (0.00)	0 (0.00)	0 (0.00)	0 (0.00)	0 (0.00)

表3 2009及2010年革兰阳性菌对常用抗菌药物的耐药率比较[n(%)]

Table 3 Comparison of the drug resistance of the G^＋ bacteria against the common antibacterial drug in 2009 and 2010 [n(%)]

抗菌药物类别	2009年		2010年
抗菌药物类别	肺炎链球菌(n＝12)	金黄色葡萄球菌(n＝8)	肺炎链球菌(n＝11)	金黄色葡萄球菌(n＝12)
青霉素	10(83.33)	8(100.00)	11(100.00)	10(83.33)
氨苄西林	9(75.00)	7 (87.50)	10 (90.91)	9(75.00)
阿莫西林	8(66.67)	5 (62.50)	10 (90.91)	9(75.00)
头孢唑林	7(58.33)	6 (75.00)	8 (72.73)	9(75.00)
氨曲南	7(58.33)	5 (62.50)	4 (36.36)	7(58.33)
头孢他啶	5(41.67)	4 (50.00)	5 (45.45)	5(41.67)
头孢噻肟	5(41.67)	3 (37.50)	4 (36.36)	6(50.00)
克拉维酸/头孢噻肟	4(33.33)	4 (50.00)	6 (54.55)	7(58.33)
克拉维酸/头孢他啶	7(58.33)	2 (25.00)	2 (18.18)	3(25.00)
亚胺培南	0 (0.00)	0(0.00)	0(0.00)	0 (0.00)

表3 2009及2010年革兰阳性菌对常用抗菌药物的耐药率比较[n(%)]

Table 3 Comparison of the drug resistance of the G^＋ bacteria against the common antibacterial drug in 2009 and 2010 [n(%)]

抗菌药物类别	2009年		2010年
抗菌药物类别	肺炎链球菌(n＝12)	金黄色葡萄球菌(n＝8)	肺炎链球菌(n＝11)	金黄色葡萄球菌(n＝12)
青霉素	10(83.33)	8(100.00)	11(100.00)	10(83.33)
氨苄西林	9(75.00)	7 (87.50)	10 (90.91)	9(75.00)
阿莫西林	8(66.67)	5 (62.50)	10 (90.91)	9(75.00)
头孢唑林	7(58.33)	6 (75.00)	8 (72.73)	9(75.00)
氨曲南	7(58.33)	5 (62.50)	4 (36.36)	7(58.33)
头孢他啶	5(41.67)	4 (50.00)	5 (45.45)	5(41.67)
头孢噻肟	5(41.67)	3 (37.50)	4 (36.36)	6(50.00)
克拉维酸/头孢噻肟	4(33.33)	4 (50.00)	6 (54.55)	7(58.33)
克拉维酸/头孢他啶	7(58.33)	2 (25.00)	2 (18.18)	3(25.00)
亚胺培南	0 (0.00)	0(0.00)	0(0.00)	0 (0.00)

表4 本组检出前5位细菌菌株中产ESBLs菌检出情况[n(%)]

Table 4 The detection rates of the producing ESBLs among top five bacteria strains [n(%)]

病原菌	n	产ESBLs菌检出率
肺炎克雷伯菌	35	17(48.57)
大肠埃希菌	27	8(29.63)
肺炎链球菌	23	6(26.09)
金黄色葡萄球菌	20	5(25.00)
铜绿假单胞菌	17	4(23.53)
合计	122	40(32.79)

表4 本组检出前5位细菌菌株中产ESBLs菌检出情况[n(%)]

Table 4 The detection rates of the producing ESBLs among top five bacteria strains [n(%)]

病原菌	n	产ESBLs菌检出率
肺炎克雷伯菌	35	17(48.57)
大肠埃希菌	27	8(29.63)
肺炎链球菌	23	6(26.09)
金黄色葡萄球菌	20	5(25.00)
铜绿假单胞菌	17	4(23.53)
合计	122	40(32.79)

1	British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in childhood [J]. Thorax, 2002，57(suppl 1):1-24.
2	McIntosh K. Community－acquired pneumonia in children [J]. N Engl J Med, 2002, 346:429-437.
3	Li Y, Wu Q, Ni L, et al. Pathogen detection and clinical study of infectious pneumonia in the newborn [J]. Chin J Neonatol, 2008, 23(3):137-140.
4	Li CC, Lin L. Common bacterial pathogens and drug resistance of pneumonia in children[J/CD]．Chin J Obstet Gynecol Pediatr：Electron Ed，2010，6(5):308-314.
5	Di JH. Pathogenic bacteria of infectious pneumonia and their antimicrobial resistance in newborn [J]. Chin Gen Pract, 2010, 13(15):1664-1666.
6	He HY, Lv X, Lv B. Analysis of etiology and drug resistance of 832 children with bacterial pneumonia[J]. J Guangdong Med Coll，2010, 28(2):164-166.
7	Chen Y. Etiology and antibiotic resistance of 626 children with bacterial pneumonia [J]. Asia-Pacific Traditional Med, 2011，7(7):177-178.
8	Wu XY, Shen CY, Gu LP. Etiology and drug resistance of children with bacterial pneumonia [J]. Chin J Nosocomiol, 2011, 21(10):2124-2126.
9	John S, Bradley, Carrie L. Byington, et al. The mfanagement of community－acquired pneumonia in infants and children older than 3 months of age: Clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America [J]. Clin Infect Dis, 2011, 53(7):e25-76.

[1]	Hongyu Tao, Jingjing Ye, Jin Yu, Xiuzhen Yang, Jingjing Qian, Bin Xu, Weize Xu, Qiang Shu. Value of contrast transthoracic echocardiography in assessing right-to-left shunt-related diseases in children[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(10): 959-965.
[2]	Xiaofei Li, Hongli Liu, Qiuling Shi, Jing Tian, Li Li, Hongbo Qi, Xin Luo. A prospective randomized controlled study of low intensity focused ultrasound uterine involution treatment for prevention and treatment of postpartum hemorrhage in natural childbirth women[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 534-539.
[3]	Qin Liu, Hanmin Liu, Liang Xie. Current status of research on the role of matrix metalloproteinases in the pathogenesis of childhood asthma[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 564-568.
[4]	Yun Xiang, You Lu, Fan Yang. Current research status of correlation between per-and polyfluoroalkyl substances exposure and childhood obesity[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 569-574.
[5]	Xiaoli Yang, Wanfu Li, Zhu Ma, Lan Ma, Yi Zheng, Xiaoli Fu, Jing Wang. Application effect of one-step forceps needle method in laparoscopic high ligation of hernia sac in children[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(05): 535-538.
[6]	Hebei Ding, Xun Wang, Weiguo Chen. Comparison of application of sevoflurane inhalation anesthesia and propofol intravenous anesthesia in pediatric indirect inguinal hernia surgery[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(05): 570-574.
[7]	Jiayi Xing, Jiasheng Gong, Jiajia Zhu, Qun Lu. Analysis of pathogenic drug resistance and inflammatory factor changes in secondary pulmonary infection in chemotherapy patients with lung cancer[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(05): 714-718.
[8]	Hui Yang, Lijuan Guo, Xiaodan Feng, Jing LI, Chengmo Huang, Xingrui Cai, Yingjiao Qin, Yuanli Wang. Expression characteristics and prediction analysis of platinum-resistant mi RNA in non-small cell lung cancer[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(05): 719-724.
[9]	Chinese Society of Organ Transplantation of Chinese Medical Association, Surgery Group of Chinese Society of Surgery of Chinese Medical Association, Transplantation Group of Chinese Society of Surgery of Chinese Medical Association, South China Alliance of Split Liver Transplantation. Chinese Clinical Practice Guidelines on Split Liver Transplantation in Children[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(05): 593-601.
[10]	Jun Liu, Wenjing Qiu, Fanghao Sun, Songying Li, Shuhong Yi, Binsheng Fu, Yang Yang, Hui Luo. Comparison of in vivo and in vitro split liver transplantation in pediatric liver transplantation[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(05): 688-693.
[11]	Xiangqian Wang, Qingfeng Li, Lei Chen, Wendan Qiu, Zhicheng Yao, Yi Li, Ronghuan Wu. Inhibitory effect of curcumin on sorafenib resistance in hepatocellular carcinoma and its regulatory mechanism[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(05): 729-735.
[12]	Chen Zhang, Ming Qin, Juan Dong, Yulong Chen. Diagnostic value of ultrasound in ischemic changes of intestinal volvulus in children[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(06): 565-568.
[13]	Qi Liu, Shoukai Wang, Shuai Wang, Yuqing Su, Zhuang Ma, Haijun Chen, Pilei Si. Advances in research of intratumoral microbiome in breast cancer[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(09): 841-845.
[14]	Xing Wang, Yuan Chen, , Wusman Rezi Wan Guli, Yanying Guo. Co-pathogenic genes and potential common molecular mechanisms of type 2 diabetes mellitus, obesity, nonalcoholic steatohepatitis, and polycystic ovary syndrome[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(05): 481-490.
[15]	Yue Yu, Yuan Wang, Muhui Sang, Qin Shi. Analysis of vertigo pathogenesis syndrome element distribution using a vertigo syndrome differentiation scale[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2024, 18(05): 454-458.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export